U.S. Investing

Yes, This Is the Cannabis Correction

If you’re new around here, it might look a little like the end of the world. Don’t panic.

Hundreds of “hot” stocks took a big step back this week. The pain is nearly universal among the cannabis-related names on my screen.

Only one of the tiniest fought its way to the upside. I’ll tell you more about it later.

This Is the Cannabis Correction: Canopy Growth

For now, I simply want to linger on the carnage as a teachable moment. The biggest stock in the industry, Canopy Growth Corp. (NASDAQ:CGC), was one of the hardest hit, lurching 14% lower.

Its up-and-coming chief competitor, Tilray Inc. (NASDAQ:TLRY), plunged 16%. Neither giants nor niche favorites were spared.

All in all, the dozen cannabis stocks I track in my proprietary index took an 11% fall. That’s a bona fide correction playing out in real time, only a little slower than the infamous “flash crash.”

This Is the Cannabis Correction When Stocks Return to Realistic Levels

But, by definition, a correction happens when stocks that have gotten ahead of themselves retrace their steps until they hit more sustainable and realistic levels. They aren’t crashing. They’re literally correcting course.

And long-term investors accept a few course corrections as part of the natural give and take of life on Wall Street. When stocks go up a lot, they can come down a little and no sensible person complains.

That’s exactly what’s happening here. Those dozen stocks I track may be down 11% this week, but they’re still up 77% in the aggregate year to date (YTD).

This Is the Cannabis Correction: Dropping 11% in a Week

In that context, giving up 11% on what was once a huge return isn’t so terrible, especially when you consider that we’re only two months into the year and these stocks still have a lot of room to run.

After all, there’s no bad news circulating around cannabis. All the indicators still point to enlarged markets and looser regulations ahead.

Wall Street agrees. Price targets on these companies are actually rising. So, don’t blame cannabis. It’s just the market tides circulating.

This Is the Cannabis Correction, Except for a Tiny Stock Recommended in IPO Edge

But what about that tiny cannabis-linked stock that still is rallying through the storm? It isn’t even listed on a major exchange. You’ll have to squint to see it.

Those who have been able to locate a few shares are cheering. Dollar for dollar, when a tiny stock triples in price in a matter of months, it feels just as good as it does when a Silicon Valley stock leaps from $300 billion to $1 trillion.

If anything, it’s more likely for little stocks to stretch than it is for a giant like Apple Corp. (NASDAQ:AAPL) or Amazon.com Inc. (NASDAQ:AMZN) to triple at this stage.a

What is the stock? Only my IPO Edge subscribers can answer that question.

Hilary Kramer

Hilary Kramer is an investment analyst and portfolio manager with 30 years of experience on Wall Street. The Financial Times describes Ms. Kramer as “A one-woman financial investment powerhouse” and The Economist distinguishes her as “one of the best-known investors in America”. Ms. Kramer is often quoted in publications such as the Wall Street JournalNew York Post, Bloomberg, and Reuters. She is a frequent guest commentator on CNBC, CBS, Fox News and Bloomberg, providing investment insight and economic analysis. Ms. Kramer was an analyst and investment banker at Morgan Stanley and Lehman Brothers.  Ms. Kramer founded and ran a long-short hedge fund and has been chief investment officer overseeing debt and equity portfolios. Since 2010, Ms. Kramer’s financial publications have provided stock analysis and investment advice to her subscribers.  Her products include GameChangers, Value Authority, High Octane Trader, Triple-Digit Trader, 2-Day Trader, IPO Edge and Inner Circle. Ms. Kramer, a Certified Fraud Examiner, has also testified as an expert in investment suitability, risk management, compliance, executive compensation, and corporate governance. Ms. Kramer received her MBA from the Wharton School at the University of Pennsylvania and her BA with honors from Wellesley College. Ms. Kramer has provided testimony regarding investment policy to the U.S. Senate and is a frequent speaker on the markets, portfolio management and securities fraud and compliance. Ms. Kramer is also the author of “Ahead of the Curve” (Simon & Schuster 2007) and “The Little Book of Big Profits from Small Stocks” (Wiley 2012).

Recent Posts

The Difference Between SPX and SPY – Options Trading

When looking to invest in the S&P 500, SPX and SPY options are similar assets…

19 hours ago

Index Options – Explained and Simplified

An index option is a contract that gives the buyer the right, but not the…

20 hours ago

The Most Hated Adage on Wall Street

“There’s more wisdom in your book than four years of college education!” -- Subscriber Back…

24 hours ago

ETF Talk: Being Prepared for Anything with an Insurance ETF

There is a famous saying that has been floating around the internet regarding the “Five…

2 days ago

May Day, Reimagined

Today is May 1, a day that’s also known as “May Day” in many countries…

2 days ago

10 Reasons to Day-Trade with Mentors in a Virtual Room

Ten reasons to day-trade with mentors in a virtual room highlight why now is a…

2 days ago